Effects of β-carotene and other factors on outcome of cervical dysplasia and human papillomavirus infection

Gynecologic Oncology

Volumn 65, Issue 3, 1997, Pages 483-492

  Romney, Seymour L ^a   Ho, Gloria Y F ^a   Palan, Prabhudas R ^a   Basu, Jayasri ^a   Kadish, Anna S ^a   Klein, Sara ^a   Mikhail, Magdy ^a   Hagan, Robert J ^a   Chang, Chee Jen ^a   Burk, Robert D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER RISK; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX DYSPLASIA; VERRUCA VULGARIS; VIRUS CARCINOGENESIS;

EID: 0031172861     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4697     Document Type: Article

References (37)

1. 1. Richart RM, Barron BA: A follow-up study of patients with cervical dysplasia. Am J Obstet Gynecol 105:386-393, 1969
2. 2. Syrjanen K, Kataja V, Yliskoski M, Chang F, Syrjanen S, Saarikoski S: Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda system. Obstet Gynecol 79:675-682, 1992
3. 3. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, DeRouen TA, Galloway DA, Vernon D, Kiviat NB: A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 327:1272-1278, 1992
4. 4. Morrison EAB, Ho GYF, Vermund SH, Goldberg GL, Kadish AS, Kelley KF, Burk RD: Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study. Int J Cancer 49:6-13, 1991
5. 5. Ho GYF, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R, Romney S: Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 87:1365-1371, 1995
6. 6. Herrero R, Potischman N, Brinton LA, Reeves WC, Brenes MM, Tenorio F, de Britton RC, Gaitan E: A case control study of nutrient status and invasive cervical cancer. I. Dietary indicators. Am J Epidemiol 134:1335-1346, 1991
7. 7. Palan PR, Mikhail MS, Basu J, Romney SL: Plasma levels of antioxidant β-carotene and α-tocopherol in uterine cervix dysplasias and cancer. Nutr Cancer 15:13-20, 1991
8. 8. Potischman N, Herrero R, Brinton LA, Reeves WC, Stacewicz-Sapuntzakis M, Jones CJ, Brenes MM, Tenorio F, de Britton RC, Gaitan E: A case-control study of nutrient status and invasive cervical cancer. II. Serologic indicators. Am J Epidemiol 134:1347-1355, 1991
9. 9. Bendich A, Olson JA: Biological actions of carotenoids. FASEB J 3:1927-1932, 1989
10. 10. Peto R, Doll R, Buckley JD, Sporn MB: Can dietary β-carotene materially reduce human cancer rates? Nature 290:201-208, 1981
11. 11. Schmidt K: Antioxidant vitamins and β-carotene: effects on immunocompetence. Am J Clin Nutr 53:383S-385S, 1991
12. 12. Burk RD, Kadish AS, Calderin S, Romney SL: Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization: correlation with biopsy results and Papanicolaou smear. Am J Obstet Gynecol 154:982-989, 1986
13. 13. Begrens WA, Madere R: A highly sensitive high performance liquid chromatography method for the estimation of ascorbic and dehydroascorbic acid in the tissues, biological fluid, and foods. Anal Biochem 165:102-107, 1987
14. 14. Palan PR, Romney SL, Vermund SH, Mikhail MG, Basu J: Effects of smoking and oral contraception on plasma β-carotene levels in healthy women. Am J Obstet Gynecol 161:881-885, 1989
15. 15. The 1988 Bethesda system for reporting cervical/vaginal cytological diagnoses: National Cancer Institute Workshop. J Am Med Assoc 262:931-934, 1989
16. 16. Inc., S. I. SAS/STAT User's Guide, Version 6, 1989, Cary, NC: SAS Institute, Inc.
17. 17. Burk RD, Ho GYF, Beardsley L, Lempa M, Peters M, Bierman R: Sexual behavior and partner characteristics are the predominant risk factors for genital HPV infection in young women. J Infect Dis 174:679-689, 1996
18. 18. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 87:796-802, 1995
19. 19. La Vecchia C, Decarli A, Fasoli M, Parazzini F, Franceschi S, Gentile A, Negri E: Dietary vitamin A and the risk of intraepithelial and invasive cervical neoplasia. Gynecol Oncol 30:187-195, 1988
20. 20. Potischman N, Brinton LA: Nutrition and cervical neoplasia. Cancer Causes Control 7:113-126, 1996
21. 21. Slattery ML, Abbott TM, Overall JC, Robison LM, French TK, Jolles C, Gardner JW, West DW: Dietary vitamins A, C, and E and selenium as risk factors for cervical cancer. Epidemiology 1:8-15, 1990
22. 22. VanEenwyk J, Davis FG, Bowen PE: Dietary and serum carotenoids and cervical intraepithelial neoplasia. Int J Cancer 48:34-38, 1991
23. 23. Ziegler RG, Brinton LA, Hamman RF, Lehman HF, Levine RS, Mallin K, Norman SA, Rosenthal JF, Trumble AC, Hoover RN: Diet and the risk of invasive cervical cancer among white women in the United States. Am J Epidemiol 132:432-445, 1990
24. 24. Mathews-Roth MM: β-Carotene, Canthaxanthin, and Phytoene, in Moon TE, Micozzi MS (eds): Nutrition and Cancer Prevention: Investigating the Role of Micronutrients. New York: Dekker, 1989, pp 273-290
25. 25. Greenberg ER, Baron JA, Stukel TA, Stevens MM, Mandel JS, Spencer SK, Elias PM, Lowe N, Nierenberg DW, Bayrd G, Vance JC, Freeman DH, Jr, Clendenning WE, Kwan T, Group, T. S. C. P. S.: A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. N Engl J Med 323:789-795, 1990
26. 26. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R: Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334:1145-1149, 1996
27. 27. Omenn GS, Goodman GE, Thornquist KD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Jr, Valanis B, Williams JH, Jr, Barnhart S, Hammar S: Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334:1150-1155, 1996
28. 28. The alpha-tocopherol and group, b. c. c. p. s.: The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330:1029-1035, 1994
29. 29. De Vet HCW, Knipschild PG, Willebrand D, Schouten HJA, Sturmans F: The effect of β-carotene on the regression and progression of cervical dysplasia: a clinical experiment. J Clin Epidemiol 44:273-283, 1991
30. 30. Nasiell K, Roger V, Nasiell M: Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol 67:665-725, 1986
31. 31. Nasiell K, Nasiell M, Vaclavinkova V: Behavior of moderate cervical dysplasia during long-term follow-up. Obstet Gynecol 61:609-614, 1983
32. 32. Brock KE, Berry G, Mock PA, MacLennan R, Truswell AS, Brinton LA: Nutrients in diet and plasma risk of in situ cervical cancer. J Natl Cancer Inst 80:580-585, 1988
33. 33. Verreault R, Chu J, Mandelson M, Shy K: A case-control study of diet and invasive cervical cancer. Int J Cancer 43:1050-1054, 1989
34. 34. Kataja V, Syrjanen K, Syrjanen S, Mantyjarvi R, Yliskoski M, Saarikoski S, Salonen JT: Prospective follow-up of genital HPV infections: survival analysis of the HPV typing data. Eur J Epidemiol 6:9-14, 1990
35. 35. Remmink AJ, Walboomers JMM, Heimerhorst TJM, Voorhorst FJ, Rozendaal L, Risse EKJ, Meijer CJLM, Kenemans P: The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 61:306-311, 1995
36. 36. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME, Kurman RJ, Manos MM: Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 169:235-240, 1994
37. 37. Ho GYF, Beardsley L, Lempa M, Qu W, Jiang G, Bierman R, Burk RD: Duration and risk factors of type-specific persistent genital HPV infection. 14th International Papillomavirus Conference, Quebec, Quebec, Canada, No. 38, 1995 (abstract)